Trial intelligence / Profile preview

Enoxaparin versus unfractionated heparin regimen in pregnant women with mechanical heart valves

IRCT20171030037093N28Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Feb 2020
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, double-blind trial of enoxaparin, heparin and warfarin in pregnancy in women with mechanical heart valves, sponsored by Isfahan University of Medical Sciences. Started Feb 2020; status: completed.

02

Drugs

enoxaparinheparinwarfarin
03

Conditions

pregnancy in women with mechanical heart valves

Beyond the preview

Go deeper on IRCT20171030037093N28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171030037093N28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call